Pharmalot By Ed Silverman Amgen and Novartis file dueling lawsuits over their deal to market a migraine drug
Pharmalot By Ed Silverman Minnesota becomes first state to sue major insulin makers over price-gouging
Pharmalot By Ed Silverman A reversal of fortunes: Judge voids order Gilead must pay $2.5B to Merck over a patent dispute
Pharmalot By Ed Silverman Pharmalittle: Supermarkets sue over generic price fixing; Daiichi can collect that $550 million award
Pharmalot By Ed Silverman Pharmalittle: Generic chief at Novartis unit leaves; how Ned Sharpless got to the top of the FDA
Pharmalot By Ed Silverman Pharmalittle: Trump grows frustrated over drug pricing; FDA enforcement declines under Trump
Pharmalot By Ed Silverman Pharmalittle: Colorado is first U.S. state to cap insulin prices; JP Morgan cuts ties with Purdue
Pharmalot By Ed Silverman Baltimore sues a J&J unit over ‘sham’ patent litigation to extend its monopoly on a cancer drug
Pharmalot By Ed Silverman Generic drug price-fixing suit is akin to earlier case, but ‘on steroids,’ Conn. prosecutor says
Pharmalot By Ed Silverman A federal appeals court just slammed the door on Allergan’s deal with the Mohawk tribe
Pharmalot By Ed Silverman Pharmalittle: Amgen migraine drug costs less than expected; J&J halts development on Alzheimer’s drug
Pharmalot By Ed Silverman Pharmalittle: Sanofi to refund Philippines for dengue vaccine; Google backs universal flu vaccine
Pharmalot By Ed Silverman Allergan to pay $4 million to settle sex discrimination charges by former sales reps
Pharmalot By Ed Silverman Pharmalittle: Shire CFO will be leaving; J&J hit with $417 million talc verdict